Computational Biology Market Share

North American Market Forecast

North America region is anticipated to gain the largest computational biology market share till 2036, due to the growing R&D activities, coupled with the high investment in research activities.

The growing foothold of the United States in synthetic biology is predicted to promote lucrative opportunities for the market expansion. The advancement of the region in the application of machine learning tools and analytical tools will further influence the market growth.

APAC Market Statistics

Asia Pacific computational biology market is expected to witness substantial demand through 2036. The increasing presence of contract research organizations in the region that reduce the cost of drug development for many pharmaceutical industries will propel the market revenue.

The Asian market is popular for the manufacturing of generic drugs and biosimilars which is much essential to decrease healthcare expenditure and is set to drive the use of computational biology in the region.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of computational biology is estimated at USD 9.33 Billion.

The computational biology market size was over USD 7.91 Billion in 2023 and is projected to cross USD 83.76 Billion by the end of 2036, witnessing more than 19.9% CAGR during the forecast period i.e., between 2024-2036. Increasing investment in research and development activities and growing demand for bioinformatics are the major factors driving the market growth.

North America is anticipated to gain the largest industry share till 2036, impelled by growing R&D activities, coupled with high investment in research activities.

Dassault Systèmes SE, Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG

Computational Biology Market Share